| Literature DB >> 28186187 |
Norio Kobayashi1,2, Naoko Miyauchi1, Nozomi Tatsuta3, Akane Kitamura1, Hiroaki Okae1, Hitoshi Hiura1, Akiko Sato1,4, Takafumi Utsunomiya4, Nobuo Yaegashi5, Kunihiko Nakai3, Takahiro Arima1.
Abstract
Disturbingly, the number of patients with oligozoospermia (low sperm count) has been gradually increasing in industrialized countries. Epigenetic alterations are believed to be involved in this condition. Recent studies have clarified that intrinsic and extrinsic factors can induce epigenetic transgenerational phenotypes through apparent reprogramming of the male germ line. Here we examined DNA methylation levels of 22 human imprinted loci in a total of 221 purified sperm samples from infertile couples and found methylation alterations in 24.8% of the patients. Structural equation model suggested that the cause of imprint methylation errors in sperm might have been environmental factors. More specifically, aberrant methylation and a particular lifestyle (current smoking, excess consumption of carbonated drinks) were associated with severe oligozoospermia, while aging probably affected this pathology indirectly through the accumulation of PCB in the patients. Next we examined the pregnancy outcomes for patients when the sperm had abnormal imprint methylation. The live-birth rate decreased and the miscarriage rate increased with the methylation errors. Our research will be useful for the prevention of methylation errors in sperm from infertile men, and sperm with normal imprint methylation might increase the safety of assisted reproduction technology (ART) by reducing methylation-induced diseases of children conceived via ART.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28186187 PMCID: PMC5301220 DOI: 10.1038/srep42336
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Background data of the men with normozoospermia, moderate oligozoospermia and severe oligozoospermia.
| Sperm concentrations | ||||
|---|---|---|---|---|
| Normal (n = 151) | Moderate (n = 40) | Severe (n = 30) | ||
| Abstinence period (days) | 5.1 ± 3.0 | 5.8 ± 9.2 | 4.6 ± 2.0 | 0.506 |
| ≤4.0 | 54.7% | 64.1% | 43.3% | 0.228 |
| 4.0< | 45.3% | 35.9% | 56.7% | |
| Volume (ml) | 3.3 ± 1.5 | 3.3 ± 1.4 | 3.1 ± 2.0 | 0.501 |
| ≤3.0 | 50.7% | 52.5% | 56.7% | 0.831 |
| 3.0< | 49.3% | 47.5% | 43.3% | |
| Motility (%) | 57.4 ± 15.6 | 42.9 ± 19.1 | 26.9 ± 23.1 | <0.001** |
| ≤53.0 | 41.7% | 70.0% | 90.0% | <0.001** |
| 53.0< | 58.3% | 30.0% | 10.0% | |
| Malformation (%) | 56.5 ± 10.0 | 60.6 ± 11.1 | 69.4 ± 11.0 | <0.001** |
| ≤58.0 | 62.7% | 47.5% | 8.0% | <0.001** |
| 58.0< | 37.3% | 52.5% | 92.0% | |
| Imprinted methylation (%) | ||||
| Normal | 83.4% | 77.5% | 30.0% | <0.001** |
| Abnormal | 16.6% | 22.5% | 70.0% | |
| Age (year) | 35.2 ± 5.7 | 36.4 ± 4.6 | 36.8 ± 6.5 | 0.326 |
| ≤35 | 53.0% | 42.5% | 46.7% | 0.456 |
| 35< | 47.0% | 57.5% | 53.3% | |
| Height (cm) | 171.0 ± 5.3 | 171.8 ± 6.2 | 172.2 ± 6.8 | 0.642 |
| ≤171.0 | 53.7% | 47.5% | 50.0% | 0.762 |
| 171.0< | 46.3% | 52.5% | 50.0% | |
| Body weight (kg) | 70.8 ± 11.3 | 71.3 ± 10.0 | 70.6 ± 9.4 | 0.859 |
| ≤70.0 | 53.7% | 45.0% | 56.7% | 0.550 |
| 70.0< | 46.3% | 55.0% | 43.3% | |
| BMI (kg/m2) | 24.2 ± 3.6 | 24.2 ± 2.9 | 23.8 ± 2.9 | 0.797 |
| ≤23.8 | 50.3% | 45.0% | 53.3% | 0.765 |
| 23.8< | 49.7% | 55.0% | 46.7% | |
| Sleeping time (hours) | 6.7 ± 0.8 | 6.7 ± 0.8 | 6.5 ± 0.9 | 0.408 |
| ≤7.0 | 85.4% | 82.9% | 88.0% | 0.856 |
| 7.0< | 14.6% | 17.1% | 12.0% | |
| Annual income (million yen) | 4.8 ± 2.2 | 5.0 ± 2.3 | 4.7 ± 1.9 | 0.921 |
| ≤4.0 | 53.3% | 50.0% | 52.2% | 0.944 |
| 4.0< | 46.7% | 50.0% | 47.8% | |
| Education (%) | ||||
| High school or less | 30.1% | 17.6% | 37.5% | 0.218 |
| College, University or Graduate school | 69.9% | 82.4% | 62.5% | |
| Residence (%) | ||||
| Farming or fishing village | 16.1% | 20.0% | 8.3% | 0.478 |
| Residential district or others | 83.9% | 80.0% | 91.7% | |
| LH (mIU/ml) | 3.0 ± 1.2 | 3.3 ± 1.2 | 5.0 ± 3.8 | 0.010* |
| FSH (mIU/ml) | 6.7 ± 4.2 | 8.3 ± 5.3 | 14.9 ± 12.1 | <0.001** |
| PRL (ng/ml) | 9.0 ± 4.2 | 10.2 ± 3.8 | 9.1 ± 4.6 | 0.159 |
| T (ng/dl) | 423.7 ± 147.3 | 446.7 ± 145.3 | 544.2 ± 263.4 | 0.136 |
| Smoking (%) | ||||
| Current smoker | 22.4% | 25.7% | 40.0% | 0.182 |
| Never smoker or ex-smoker | 77.6% | 74.3% | 60.0% | |
| Exercise (%) | ||||
| Exerciser | 48.4% | 61.8% | 29.2% | 0.050 |
| Non-exerciser | 51.6% | 38.2% | 70.8% | |
Data are shown as mean ± SD. Numbers within brackets indicate the number of patients studied. All questionnaires were categorized into two groups, and the three classifications were patients with normozoospermia (Normal), moderate oligozoospermia (Moderate) and severe oligozoospermia (Severe). The results of serum pituitary hormone examination are shown as blood parameters (luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin (PRL) and testosterone (T)). Significant differences were determined using the chi-squared test or Kruskal-Wallis test. *P < 0.05, **P < 0.01.
Total PCBs and their isoform concentrations in the three sperm groups.
| Sperm concentrations | ||||
|---|---|---|---|---|
| Normal (n = 55) | Moderate (n = 33) | Severe (n = 25) | ||
| Total PCB | 46.8 ± 37.3 | 74.1 ± 35.0 | 75.4 ± 50.0 | <0.001** |
| ≤51.9 | 69.1% | 30.3% | 36.0% | <0.001** |
| 51.9< | 30.9% | 69.7% | 64.0% | |
| #70/80 | 3.2 ± 2.6 | 3.7 ± 1.7 | 2.9 ± 2.0 | 0.014* |
| #99 | 2.5 ± 1.8 | 3.0 ± 1.6 | 3.2 ± 2.4 | 0.032* |
| #118 | 2.8 ± 2.7 | 3.8 ± 2.2 | 4.3 ± 3.1 | 0.001** |
| #153 | 8.7 ± 8.6 | 6.1 ± 5.0 | 6.3 ± 3.5 | 0.854 |
| #163/164 | 11.1 ± 15.2 | 19.3 ± 10.4 | 20.3 ± 15.4 | <0.001** |
| #138 | 6.9 ± 6.5 | 9.8 ± 5.6 | 11.3 ± 9.2 | 0.002** |
| #182/187 | 3.0 ± 4.9 | 10.1 ± 7.0 | 8.5 ± 7.2 | <0.001** |
| #180 | 6.7 ± 7.3 | 13.3 ± 8.0 | 14.1 ± 9.3 | <0.001** |
| #170 | 2.1 ± 1.9 | 5.1 ± 3.1 | 4.5 ± 3.7 | <0.001** |
Total serum PCBs and their isoforms were measured in 113 randomly selected subjects by high-resolution gas chromatography and high-resolution mass spectrometry using isotope dilution. Data are shown as mean ± SD. Numbers within brackets indicate the number of patients studied. The three classifications were patients with normozoospermia, moderate oligozoospermia and severe oligozoospermia. Significant differences were determined using the chi-squared test or the Kruskal-Wallis test. *P < 0.05, **P < 0.01.
Figure 1Multivariable analysis of severe oligozoospermia, aberrant methylation and related factors using structural equation modeling.
Model results in good overall fit (χ2(16) = 10.546 (p = 0.837), GFI = 0.971, AGFI = 0.934, CFI = 1.000, RMSEA = 0.0001). Standardized coefficients are shown above the arrows. Coefficients of determination are shown at the upper right of each factor (severe oligozoospermia abberant methylation, total PCB concentrations and habitual exercise). †P < 0.10, *P < 0.05, **P < 0.01.
Outcome of ART treatment with imprinted methylation and concentrations of sperm.
| Pregnancy (%) | 32.7% | (51/156) | 39.7% | (25/63) | 0.325 | ||
| Miscarriage (%) | 10.9% | (17/156) | 25.4% | (16/63) | 0.007** | ||
| Live-birth (%) | 21.8% | (34/156) | 14.3% | (9/63) | 0.205 | ||
| Pregnancy (%) | 40.0% | (40/100) | 26.6% | (21/79) | 37.5% | (15/40) | 0.159 |
| Miscarriage (%) | 12.0% | (12/100) | 13.9% | (11/79) | 25.0% | (10/40) | 0.142 |
| Live-birth (%) | 28.0% | (28/100) | 12.7% | (10/79) | 12.5% | (5/40) | 0.017* |
ART treatments indicates the number of ART treatments. Miscarriages and live births indicate the numbers of miscarriages and live births after ART treatment. The pregnancy rates (pregnancies/ART treatments), miscarriage rates (miscarriages/ART treatments) and live-birth rates (live births/ART treatments) were compared for sperm with and without abnormal imprint methylation (the upper section). In the lower section, the miscarriage rates, live-birth rates and pregnancy rates were compared according to the classification of the sperm. Significant differences were determined using the chi-squared test. *P < 0.05, **P < 0.01.